New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
Results from a clinical trial conducted at WashU Medicine showed adding the investigational drug itacitinib to standard care for “half-matched” stem cell transplantation may reduce rates of graft-versus-host disease.
Evers honored with mentoring award
The Foundation for Anesthesia Education and Research has announced that Alex Evers, MD, the Henry E. Mallinckrodt Professor of Anesthesiology at Washington University School of Medicine in St. Louis, will receive the foundation’s 2024 Mentoring Excellence in Research Award.
Siteman Cancer Center’s new outpatient building named in honor of Gary C. Werths
Siteman Cancer Center’s new building for outpatient care will be named the Gary C. Werths Building. A transformative commitment by the late Werths and his husband, Richard Frimel, will support cancer research and medical student scholarships.
Grant supports resources for the brain imaging community
Adam Eggebrecht, an associate professor of radiology at WashU Medicine, received $4 million from the National Institutes of Health (NIH) to disseminate powerful cloud-based resources to the brain mapping community.
Probiotic delivers anticancer drug to the gut
Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.
Researchers define new subtypes of common brain disorder
Researchers at WashU have used AI tools to describe three sub-types of Chiari type-1, which will help guide clinicians to make the most effective treatment decisions for their patients.
University departments win CASE awards
Content and projects produced by University Marketing & Communications and other departments across WashU recently won national and several regional awards from the Council for Advancement and Support of Education.
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Researchers at WashU Medicine have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.
Vaccine shows promise against aggressive breast cancer
A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
WashU Medicine, BJC Health System launch Center for Health AI
Washington University School of Medicine in St. Louis and BJC Health System have launched the joint Center for Health AI. The center will focus on making care more personalized and effective for patients and more efficient and manageable for physicians, nurses and all those striving to ensure patients receive the best care.
View More Stories